Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2026-02-17 @ 11:13 PM
Study NCT ID:
NCT00846768
Status:
COMPLETED
Last Update Posted:
2014-07-01
First Post:
2009-02-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPD
Sponsor:
Boehringer Ingelheim
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1222.26
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Boehringer Ingelheim, Study Chair
Old Organization:
Boehringer Ingelheim